Research Article

Ovarian and cervical cancer.

BMJ 1992; 304 doi: https://doi.org/10.1136/bmj.304.6840.1501 (Published 06 June 1992) Cite this as: BMJ 1992;304:1501
  1. C. Williams
  1. Royal South Hants Hospital, Southampton.

    Abstract

    Death rates from cervical cancer have already fallen this century and for patients with invasive cervical cancer five year survival rates are greater than for most solid tumours. Better screening for premalignant changes may further reduce the incidence of invasive cancer; indeed, it has been claimed that the reduction in mortality could be as high as 90%, though estimates of screening efficacy have varied greatly. For those with advanced invasive carcinoma neoadjuvant chemotherapy may reduce the risk of relapse and improve survival.